trial

Glutamate, Learning, and Working Memory

NCTId NCT02769936
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Completed
Enrollment 110 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2015-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Completed
Enrollment
110 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2013-11
Primary completion
2015-07
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
d-cycloserine

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor

Sites

0 total

Facts & assertions

4 sourced
Enrollment
110
Phase
PHASE1
Primary Completion Date
2015-07
Status
COMPLETED
relationships
The graph out of here
drug
d-cycloserine
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
indication
Schizophrenia
indication
Schizophrenia
indication